SIEMENS HEALTHCARE
RAPIDPOINT 500E · Cardiovascular
Related Cybersecurity Alerts
510(k) Clearances (1)
Substantially Equivalent
Recalls (2)
Siemens Healthineers has identified an issue with the RAPIDPoint500e system software version 5.3. This issue affects how the sample source is identified at the LIS when using the capillary mode. With this software version, samples run in the capillary mode are incorrectly labeled as arterial when displayed on the LIS, leading to the potential for results to be flagged according to an established a…
There are potential drug interferences from Perhexiline Maleate or Atomoxetine Hydrochloride that may cause falsely elevated sodium results reported on the RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems. The erroneous sodium levels with positive bias may lead to unrecognized hyponatremia and/or the inappropriate treatment of hypernatremia may lead to iatrogenic hyponatremia, resulted in a de…
MAUDE Adverse Events (10)
FDA Classification (63)
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular